• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of advisory committee members participating in meetings in the month who were granted waivers

Dictionary: When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the requirements set forth by 18 U.S.C. 208 are met. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver.

Information is current as of June 30, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetPercent Granted Waivers
Oct 2013N/A0
Nov 2013N/A0
Dec 2013N/A0
Jan 2014N/A0
Feb 2014N/A0
Mar 2014N/A0
Apr 2014N/A0
May 2014N/A1.45
Jun 2014N/A0
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 0.11%

Total number of advisory committee members participating in meetings in the month who were granted waivers

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetWaivers Granted
Oct 2013N/A0
Nov 2013N/A0
Dec 2013N/A0
Jan 2014N/A0
Feb 2014N/A0
Mar 2014N/A0
Apr 2014N/A0
May 2014N/A1
Jun 2014N/A0
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 1

Total number of advisory committee members participating in meetings in the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetCommittee Members
Oct 2013N/A103
Nov 2013N/A106
Dec 2013N/A108
Jan 2014N/A55
Feb 2014N/A159
Mar 2014N/A105
Apr 2014N/A73
May 2014N/A69
Jun 2014N/A92
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 870

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.